Chembond Material Technologies Limited Approves Grant of Stock Options Under ESOP 2025
Chembond Material Technologies Limited has approved the grant of stock options to eligible employees of the company and its subsidiary under the Chembond Material Technologies Limited - Employee Stock Option Plan 2025 (CHEMBOND-ESOP 2025). The approval was granted by the Nomination and Remuneration Committee during its meeting held on July 17, 2026.The employee stock option plan is structured in accordance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. Under this specific scheme, a total of 50,738 stock options have been granted to eligible employees. Each option is convertible into one fully paid up equity share carrying a face value of ₹ 5/- each.
The company has established an exercise price of ₹ 171/- per share for the equity shares corresponding to the 50,738 options. The vesting period for these options is set to occur within a maximum timeframe of 5 years from the Grant Date, with a mandatory minimum gap of 1 year between the Grant Date and the Vesting of the options.
The following table outlines the key details of the approved stock option grant:
| Particulars | Details |
|---|---|
| Total Options Granted | 50,738 |
| Exercise Price | ₹ 171/- per share |
| Face Value per Share | ₹ 5/- |
| Vesting Period | Maximum of 5 years from Grant Date |
| Minimum Gap for Vesting | 1 year from Grant Date |
| Regulatory Alignment | SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 |
CHEMBOND Stock Price Movement
Chembond Material Technologies Limited shares rallied to close at ₹180.49 today, gaining 1.98%. The stock climbed from a session low of ₹174.1 on a volume of 2,286 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.